Attached files

file filename
EX-31.1 - CERTIFICATION CEO - NEOMAGIC CORPex31-1.htm
EX-31.2 - CERTIFICATION CFO - NEOMAGIC CORPex31-2.htm
EX-32.2 - CERTIFICATION CFO - NEOMAGIC CORPex32-2.htm
EX-32.1 - CERTIFICATION CEO - NEOMAGIC CORPex32-1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
 
Form 10-Q
 
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended October 31, 2010
 
OR
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                to               
 
Commission file number 000-22009

NEOMAGIC CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
 
DELAWARE
 
77-0344424
(State or Other Jurisdiction of Incorporation or Organization)
 
(I.R.S. Employer Identification No.)
     
2372-A Qume Drive, San Jose, California
 
95131
(Address of Principal Executive Offices)
 
(Zip Code)

(408) 428-9725
Registrant’s Telephone Number, Including Area Code
 
 
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x  No o

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yeso  Noo

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large Accelerated Filer o   Accelerated Filer o   Non- Accelerated Filer o   Smaller Reporting Company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yeso No x
 
The number of shares of the Registrant’s Common Stock, $.001 par value, outstanding at November 30, 2010 was 64,832,354.
 
 
 

 
 
NEOMAGIC CORPORATION
FORM 10-Q
 
INDEX
 
 
 
 
 
 
PAGE
PART I. FINANCIAL INFORMATION
 
 
 
 
 
Item 1.
 
Financial Statements:
 
 
 
 
 
 
 
Unaudited Condensed Consolidated Statements of Operations
   Three and Nine months ended October 31, 2010 and November 1, 2009
 
1
 
 
 
 
 
Condensed Consolidated Balance Sheets
   October 31, 2010 (unaudited) and January31, 2010
 
2
 
 
 
 
 
Unaudited Condensed Consolidated Statements of Cash Flows
   Nine months ended October 31, 2010 and November 1, 2009
 
3
 
 
 
 
 
Notes to Unaudited Condensed Consolidated Financial Statements
 
4
 
 
 
Item 2.
 
Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
12
 
 
 
Item 3.
 
Quantitative and Qualitative Disclosures about Market Risk
 
16
 
 
 
Item 4.
 
Controls and Procedures
 
16
 
 
 
 
 
 
 
PART II. OTHER INFORMATION
 
 
 
 
 
Item 1A.
 
Risk Factors
 
18
 
 
 
Item 5.
 
Other Information
 
23
 
 
 
 
 
Item 6.
 
Exhibits
 
24
 
 
Signatures
 
25
 
 
Certifications
 
Attached
 
 
 

 
 
Part I. FINANCIAL INFORMATION

Item 1.
Financial Statements

NEOMAGIC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
October 31,
2010
   
November 1,
2009
 
 
October 31,
2010
 
 
November 1,
2009
 
Net revenue
 
$
275
   
$
348
 
 
$
807
 
 
$
1,204
 
Cost of revenue
 
 
118
     
174
 
 
 
338
 
 
 
532
 
Gross profit
   
157
     
174
 
 
 
469
 
 
 
672
 
Operating expenses:
   
 
     
 
 
 
 
 
 
 
 
 
 
Research and development
   
62
     
131
 
 
 
490
 
 
 
(366
)
Sales, general and administrative
   
225
     
269
 
 
 
1,371
 
 
 
2,252
 
Restructuring expense (income)
   
     
(282
)
 
 
 
 
 
(349
)
Total operating expenses
   
287
     
118
 
 
 
1,861
 
 
 
1,537
 
Operating income (loss)
   
(130
)
 
 
56
 
 
 
(1,392
)
 
 
(865
)
Other income (expense), net:
                               
Interest income and other
   
1
     
 
 
 
2
     
25
 
Gain (loss) from change in fair value of
    warrant liability
   
     
(7
)
 
 
2
     
(7
)
Gain on debt forgiveness
   
     
2,456
     
     
2,492
 
Profit (loss) before income taxes
   
(129
)
 
 
2,505
     
(1,388
)
 
 
1,645
 
Income tax provision
   
 
 
 
     
 
 
 
 
Net income (loss)
 
$
(129
)
 
$
2,505
 
 
$
(1,388
)
 
$
1,645
 
                                 
Basic and diluted net income (loss) per share
 
$
0.00
 
 
$
0.14
 
 
$
(0.02
)
 
$
0.12
 
Weighted average common shares outstanding
    basic and diluted
 
 
64,832
 
 
 
17,313
 
 
 
60,716
 
 
 
14,112
 
 
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.
 
 
1

 
 
 NEOMAGIC CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
 
 
 
October 31,
2010
   
January 31,
2010
 
ASSETS
 
(unaudited)
   
 
 
Current assets:
 
 
   
 
 
Cash and cash equivalents
 
$
437
   
$
31
 
Accounts receivable, less allowance for doubtful accounts of $0 at
     October 31, 2010 and January 31, 2010
 
 
83
   
 
185
 
Inventory, net
 
 
91
   
 
110
 
Prepaid deposits
 
 
5
   
 
5
 
Prepaid expenses
 
 
13
   
 
44
 
Total current assets
 
 
629
   
 
375
 
Property, plant, and equipment
 
 
4
   
 
5
 
Total assets
 
$
633
   
$
380
 
 
 
 
 
   
 
 
 
LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
 
 
   
 
 
 
Current liabilities:
 
 
 
   
 
 
 
Accounts payable
 
$
163
   
$
408
 
Accrued compensation and related benefits
 
 
233
   
 
581
 
Income taxes payable
 
 
40
   
 
40
 
Warrant liability
 
 
   
 
2
 
Other accruals
 
 
268
   
 
226
 
Total current liabilities
   
704
     
1,257
 
Commitments and contingencies (Note 10)
   
 
     
 
 
Stockholders’ deficit:
   
 
     
 
 
Preferred stock, $.001 par value:
   
 
     
 
 
Authorized shares—2,000,000
   
 
     
 
 
Issued and outstanding shares – none at October 31, 2010 and January 31, 2010
   
     
 
Common stock, $.001 par value: Authorized shares—200,000,000 Issued
  and outstanding shares – 64,832,354 at October 31, 2010 and 38,051,394 at
  January 31, 2010
   
65
     
38
 
Additional paid-in-capital
   
126,790
     
124,623
 
Accumulated deficit
   
(126,926
)
 
 
(125,538
)
Total stockholders’ deficit
   
(71
)
 
 
(877
)
Total liabilities and stockholders’ deficit
 
$
633
 
 
$
380
 
 
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.
 
 
2

 
 
NEOMAGIC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
 
    Nine Months Ended  
    October 31,
2010
    November 1,
2009
 
    (in thousands)  
Operating activities:
           
Net income (loss)
 
$
(1,388
)
 
$
1,645
 
Adjustments to reconcile net income (loss) to net cash used in operating activities:
   
 
   
 
 
 
Depreciation
   
1
   
 
 
Decrease in patents payable
   
   
 
(270
)
Gain (loss) from change in fair value on revaluation of
    warrant liability
   
(2
)
 
 
7
 
Gain on debt forgiveness
   
   
 
(2,492
)
Net recoveries on inventory
   
(31
)
   
 
Stock-based compensation
   
635
     
267
 
Provision for allowance for bad debts
           
8
 
Changes in operating assets and liabilities:
   
 
       
 
Accounts receivable
   
102
     
(94
)
Inventory
   
50
     
30
 
Prepaid and other current assets
   
31
 
   
6
 
Interest receivable
   
(2
)
   
 
Accounts payable
   
(245
)
   
347
 
Accrued compensation and related benefits
   
(273
)
   
(298
)
Commissions payable
   
(75
)
   
 
Other accruals
   
42
 
   
281
 
Net cash used in operating activities
   
(1,155
)
   
(563
)
Investing activities
   
 
 
   
 
 
Purchases of short-term investments
   
(386
)
   
 
Maturities of short-term investments
   
388
 
   
 
Net cash provided by investing activities
   
2
     
 
Financing activities
   
 
 
   
 
 
Net proceeds from issuance of common stock
   
1,559
 
   
734
 
Net cash provided by financing activities
   
1,559
 
   
734
 
Net increase  in cash and cash equivalents
   
406
 
 
 
171
 
Cash and cash equivalents at beginning of period
   
31
 
 
 
183
 
Cash and cash equivalents at end of period
 
$
437
 
 
$
354
 
Supplemental schedules of cash flow information
 
 
 
 
 
 
 
 
Cash paid during the quarter for:
 
 
 
 
 
 
 
 
Interest
 
$
 
 
$
 
Taxes paid
 
$
 
 
$
 
Supplemental disclosure of non-cash investing activities:
 
 
 
 
 
 
 
 
Change in fair value of marketable equity securities
 
$
 
 
$
 
Issuance of common stock related to debt settlement
 
$
   
$
25
 
 
The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements.
 
 
3

 
 
NEOMAGIC CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1.
Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and include the accounts of NeoMagic Corporation and its wholly owned subsidiaries (collectively “NeoMagic” or the “Company”). Certain information and footnote disclosures, normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company, the financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the financial position at October 31, 2010, and the operating results for the three and nine months ended October 31, 2010 and November 1, 2009 and cash flows for the nine months ended October 31, 2010 and November 1, 2009. These financial statements and notes should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended January 31, 2010, included in the Company’s Form 10-K filed with the Securities and Exchange Commission on May 17, 2010. In February 2009, the Company’s subsidiaries in Israel and India became inactive.  NeoMagic is not involved with any variable interest entities. Intercompany accounts and transactions have been eliminated.

The Company does not believe its current cash and cash equivalents will satisfy its projected cash requirements through the next twelve months and there exists substantial doubt about the Company’s ability to continue as a going concern without a substantial investment or a significant increase in sales. The audit report of our independent registered public accounting firm with respect to our fiscal year ended January 31, 2010, included an explanatory paragraph for a “going concern”. During the quarter ended October 31, 2010, the Company decreased its cash expenditures by reducing employees’ compensation by 21%.  The Company is taking steps to generate cash by seeking funding from strategic partners and further equity financing. While we may secure financing independently, the Company is currently in talks with several groups who specialize in financing Silicon Valley high-tech companies. We anticipate finalization of our strategy in pursuing further financing during our fourth quarter ended January 30, 2011.We cannot assure you that further financing will be available on acceptable terms or at all. The adequacy of the Company’s resources will depend largely on its ability to complete additional financing and its success in re-establishing profitable operations and positive operating cash flows.

The results of operations for the nine months ended October 31, 2010 are not necessarily indicative of the results that may be expected for the year ending January 30, 2011.

The Company’s fiscal year end is the last Sunday in January. The third fiscal quarters of 2011 and 2010 ended on October 31, 2010 and November 1, 2009, respectively. The Company’s quarters generally have 13 weeks. The third quarter of fiscal 2011 and fiscal 2010 had 13 weeks. The Company’s fiscal years generally have 52 weeks. Fiscal year 2011 has 52 weeks and fiscal year 2010 had 53 weeks.

2.
Stock-Based Compensation

At October 31, 2010, the Company had several stock-based employee compensation plans, including stock option plans and an employee stock purchase plan. Stock options may be issued to directors, officers, employees and consultants (“Service Providers”) under the Company’s 2003 Stock Option Plan, as amended, Amended 1998 Stock Option Plan, and 1993 Stock Option Plan. The stock options generally vest over a two-year period or a four-year period, have a maturity of six years or ten years from the issuance date, and have an exercise price equal to the closing price on the “pink sheets” of the common stock on the date of grant. Generally, unvested options are forfeited 30 to 90 days from the date a Service Provider ceases to be a Service Provider, or in the case of death or disability, the post-exercise period may extend for a period of up to 12 months. To cover the exercise of vested options, the Company issues new shares from its authorized but unissued share pool. At October 31, 2010, approximately 19,812,877, 96,921 and 2,800 shares of the Company’s registered common stock were reserved for issuance under the 2003 Stock Option Plan, as amended, Amended 1998 Stock Option Plan, and 1993 Stock Option Plan, respectively.
 
 
4

 

In accordance with the 2003 Stock Plan, as amended (the “2003 Plan”), the Board of Directors may grant nonstatutory stock options and stock purchase rights to employees, consultants and directors. Incentive stock options may be granted only to employees. The 2003 Plan terminates in 2013. The Board of Directors determines vesting provisions for stock purchase rights and options granted under the 2003 Plan. Stock options expire no later than ten years from the date of grant. Generally stock options vest over a period of four years when granted to new employees. In the event of voluntary or involuntary termination of employment with the Company for any reason, with or without cause, all unvested options are forfeited and all vested options must be exercised within a 90-day period or as set forth in the option agreement, or they are forfeited. Certain of the options and stock purchase rights are exercisable immediately upon grant. However, common shares issued on exercise of options before vesting are subject to repurchase by the Company. As of October 31, 2010, no shares of common stock were subject to this repurchase provision. Other options granted under the 2003 Plan are exercisable during their term in accordance with the vesting schedules set forth in the option agreement.

Under the 1998 Nonstatutory Stock Option Plan (the “1998 Plan”), the Board of Directors may grant nonstatutory stock options to employees, consultants and officers. The 1998 Plan terminated automatically in June 2008. No additional options may be granted under the 1998 Plan.

Under the 1993 Stock Plan (the “1993 Plan”), the Board of Directors may grant incentive stock options to employees and nonstatutory stock options and stock purchase rights to employees, consultants and directors. The 1993 Plan terminated as to future grants in September 2003. No additional options may be granted under the 1993 Plan.

Stock Compensation Expense

Stock-based compensation expense, recorded in cost of revenue, research and development expenses, and sales and general and administrative expenses, represents the amortization of the fair value of share-based payments made to employees, members of our board of directors and other service providers in the form of stock options and purchases under the employee stock purchase plan, as we adopted the provision of ASC 718, “Share-Based Payment”, on the first day of fiscal 2007. The fair value of stock options granted and rights granted to purchase our common stock under the employee stock purchase plan is recognized as expense over the requisite service period.

The following table shows total stock-based compensation expense included in the accompanying Condensed Consolidated Financial Statements for the three and nine months ended October 31, 2010 and November 1, 2009.

 
Three Months Ended
 
Nine Months Ended
 
 
October 31,
2010
 
November 1,
2009
 
October 31,
2010
 
November 1,
2009
 
 
(In thousands)
 
Cost of revenue
$ 4   $ 4   $ 13   $ 12  
Research and development
      4         13  
Sales, general and administrative
  111     76     622     242  
Total
$ 115   $ 84   $ 635   $ 267  

For the nine months ended October 31, 2010 and November 1, 2009, the total compensation cost related to unvested stock-based awards granted to employees under the stock option plans but not yet recognized was approximately $532 and $368 thousand, respectively, including estimated forfeitures. The cost will be recognized on a straight-line basis over an estimated weighted average period of approximately 3.53 years and 1.72 years for the nine months ended October 31, 2010 and November 1, 2009, respectively, for stock options and will be adjusted if necessary in subsequent periods if actual forfeitures differ from those estimates. There was no outstanding compensation cost related to options to purchase common shares under the ESPP for the nine months ended October 31, 2010 and November 1, 2009 as the ESPP was suspended in July 2008.

There were no net cash proceeds from the sales of common stock under employee stock purchase and stock option plans for the nine months ended October 31, 2010 and November 1, 2009. No income tax benefit was realized from the sales of common stock under employee stock purchase and stock option plans during the nine months ended October 31, 2010 and November 1, 2009. The Company presents excess tax benefits from the exercise of stock options, if any, as financing cash flows rather than operating cash flows.

Determining Fair Value

Valuation and amortization method – The Company estimates the fair value using a Black-Scholes option pricing formula and a single option award approach. This fair value is then amortized ratably over the requisite service periods of the awards, which is generally the vesting period.
 
 
5

 

Expected term—The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding. The expected term for our third fiscal quarter ended October 31, 2010 is based upon historical review.

Expected Volatility – The Company’s expected volatility for the quarter ended October 31, 2010 is computed based on the Company’s historical stock price volatility. The Company believes historical volatility to be the best estimate of future volatility and noted no unusual events that might indicate that historical volatility would not be representative of future volatility.

Risk-Free Interest Rate—The risk-free interest rate used in the Black-Scholes option valuation method is based on the implied yield currently available on U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the option.

Expected Dividend—The dividend yield reflects that the Company has never paid any cash dividends and has no intention to pay dividends in the foreseeable future.

Estimated Forfeiture – The estimated forfeiture rate generally is based on an analysis of the Company’s historical forfeiture rates. With a restructuring of the Company in 2009, we determined that a historical perspective was not applicable to its current structure. The estimated average forfeiture rate for the quarters ended October 31, 2010 and November 1, 2009 was 0% and 76.08%, respectively.

In the three and nine months ended October 31, 2010 the fair value of each option grant was estimated on the date of grant using the Black-Scholes option valuation model and the ratable attribution approach using a dividend yield of 0% and the following weighted average assumptions:.
   
Option Plans
   
Three Months Ended
   
Nine Months Ended
   
October 31,
2010
   
November 1,
2009
   
October 31,
2010
   
November 1,
2009
Risk-free interest rates
    1.97 %     n/a *     1.32 %     n/a *
Volatility
    2.94       n/a *     3.45       n/a *
Expected life of option in years
    7.45       n/a *     4.38       n/a *
*No options were granted in the three and nine months ended November 1, 2009.
Our Board of Directors suspended the ESPP program in July 2008. Subsequently, no additional grants have been made to the ESPP program.

For the three and nine months ended November 1, 2009, there were no stock options granted. For the quarter ended October 31, 2010, there were 1,078,020 non-qualified options granted

Stock Options and Awards Activities

The following is a summary of the Company’s stock option activity under the stock option plans as of October 31, 2010 and related information:
 
 
Shares
 
 
Weighted Average
Exercise Price
(per share)
 
Weighted Average
Remaining Contractual
Term (in Years)
 
Aggregate
Intrinsic Value
(in thousands)
Outstanding at January 31, 2010
1,925,129
    $
2.21
 
 3.79
   $  
Granted
12,278,020
     
0.09
         
Exercised
     
         
Forfeitures and cancellations
(601,200
)    
3.05
         
Outstanding at October 31, 2010
13,601,949
 
 
$
0.26
 
5.75
 
$
Vested and Expected to Vest
13,601,949
 
 
$
0.26
 
5.75
 
$
Exercisable at October 31, 2010
6,896,129
 
 
$
0.41
 
3.27
 
$

The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on the Company’s closing stock price of $0.04 per share at October 29, 2010, the last market day of our fiscal quarter ended October 31, 2010, which would have been received by option holders had all option holders exercised their options that were in-the-money as of that date. There were no in-the-money options exercisable as of October 31, 2010 and November 1, 2009.
 
 
6

 

The exercise prices for options outstanding and exercisable as of October 31, 2010 and their weighted average remaining contractual lives were as follows:
 
 
 
Outstanding
 
 
Exercisable
 
Range of Exercise
Prices
 
Shares
Outstanding
   
Weighted
Average
Remaining
Contractual
Life
   
Weighted
 Average
 Exercise
 Price
   
Number
 Exercisable
   
Weighted
Average
Exercise
Price
 
(per share)
 
(in thousands)
   
(in years)
   
(per share)
   
(in thousands)
   
(per share)
 
$
 0.06 – 0.06
   
1,243
 
 
 
6.92
   
$
0.06
     
250
   
$
0.06
 
$
 0.07 – 0.07
   
3,250
 
 
 
2.58
   
$
0.07
     
3,167
   
$
0.07
 
$
 0.08 – 0.08
   
5,855
 
 
 
8.56
   
$
0.08
     
534
   
$
0.08
 
$
 0.15 – 0.18
   
2,875
 
 
 
3.35
   
$
0.16
     
2,604
   
$
0.16
 
$
 0.19 – 4.06
   
133
 
 
 
6.50
   
$
1.83
     
102
   
$
1.88
 
$
 4.07 and over
   
246
 
 
 
2.59
   
$
8.21
     
239
   
$
8.28
 
 
 
   
13,602
 
 
 
5.75
   
$
0.26
     
6,896
   
$
0.41
 

3.
Income (loss) Per Share

The following data shows the amounts used in computing income (loss) per share and the effect on the weighted-average number of shares of diluted potential common stock.
 
   
Three Months Ended
 
 
Nine Months Ended
 
(in thousands except per share data)
 
October 31,
2010
   
November 1,
2009
   
October 31,
2010
 
 
November 1,
2009
 
Numerator:
 
 
   
 
   
 
 
 
 
 
Net income (loss)
 
$
(129
)
 
$
2,505
   
$
(1,388
)
 
$
1,645
 
Denominator:
 
 
 
   
 
 
     
 
 
 
 
 
 
Denominator for basic net income (loss)
  per share, weighted average shares
 
 
64,832
   
 
17,313
     
60,716
 
 
 
14,112
 
Effect of dilutive securities:
 
 
 
   
 
 
     
 
 
 
 
 
 
Stock options outstanding
 
 
 
 
 
 
 
 
 
 
 
 
Denominator for diluted net income (loss)
  per share, weighted average shares
 
 
64,832
 
 
 
17,313
 
 
 
60,716
 
 
 
14,112
 
Basic and diluted net income (loss) per share
 
$
0.00
 
 
$
0.14
 
 
$
(0.02
)
 
$
0.12
 

During the three months ended October 31, 2010 and November 1, 2009, the Company excluded from the computation of basic and diluted income (loss) per share options and warrants to purchase 39,364,903 and 48,100,918 shares of common stock, respectively, because the effect would be anti-dilutive. During the nine months ended October 31, 2010 and November 1, 2009, the Company excluded from the computation of basic and diluted loss per share options and warrants to purchase 31,979,072 and 48,141,487 shares of common stock, respectively, because the effect would be anti-dilutive.
 
4.
Cash and Cash Equivalents

All highly liquid investments purchased with an original maturity of 90 days or less are considered cash equivalents. Investments with an original maturity of greater than 90 days, but less than one year, are classified as short-term investments.
 
     
Gross
     
 
   
Unrealized
 
Fair
 
October 31, 2010
Balance
 
Gain (Loss)
 
Value
 
 
(in thousands)
 
Cash and cash equivalents:
   
Money market funds
  $ 415     $     $ 415  
Bank accounts
    22             22  
Total
  $ 437     $     $ 437  

 
7

 

January 31, 2010
Balance
 
Gross
Unrealized
Gain (Loss)
 
Fair
Value
 
 
(in thousands)
 
Cash and cash equivalents:
   
Money market funds
  $ 14     $     $ 14  
Bank accounts
    17             17  
Total
  $ 31     $     $ 31  

Fair Value of Financial Instruments

On January 28, 2008, the Company adopted ASC 820 (formerly SFAS 157, “Fair Value Measurements”), which defines fair value, establishes a framework for using fair value to measure assets and liabilities, and expands disclosures about fair value measurements. ASC 820 applies whenever other statements require or permit assets or liabilities to be measured at fair value. ASC 820 is effective for the Company beginning January 28, 2008, except for non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a nonrecurring basis.

The Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

ASC 820 includes a fair value hierarchy that is intended to increase consistency and comparability in fair value measurements and related disclosures. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair value that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources while unobservable inputs reflect a reporting entity’s pricing based upon their own market assumptions. The fair value hierarchy consists of the following three levels:
 
Level 1
Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2
Inputs are quoted prices for similar assets or liabilities in an active market, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data.
Level 3
Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable (i.e., supported by little or no market activity).
 
The following table summarizes the Company’s financial assets measured at fair value on a recurring basis as of October 31, 2010 and the basis for that measurement:

         
(Level 1)
 
   
 
Balance as of
October 31, 2010
   
Quoted Prices in
Active Markets of
Identical Assets
 
   
(amounts in thousands)
 
Money market funds
  $ 415     $ 415  

The Company’s financial assets are valued using market prices on both active markets (Level 1) and less active markets (Level 2). Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 instrument valuations are obtained from readily-available pricing sources for comparable instruments.  As of October 31, 2010, the Company did not have any assets with valuations obtained from readily-available pricing sources for comparable instruments (Level 2 assets) or those without observable market values, which would require a high level of judgment to determine fair value (Level 3 assets).
 
ASC 825 also became effective the first quarter of fiscal 2009. This option was not chosen, so marketable securities continue to be accounted for as available-for-sale securities under ASC 320 (formerly SFAS 115 “Accounting for Certain Investments in Debt and Equity Securities”).
 
 
8

 

5.
Inventory

Inventory is stated at the lower of cost or market value. Cost is determined by the first-in, first-out method. The Company writes down the inventory value for estimated excess and obsolete inventory, based on management’s assessment of future demand and market conditions. If actual future demand or market conditions are less favorable than those projected by management, additional inventory write-downs may be required.
 
 
October 31,
2010
 
January 31,
2010
 
 
(unaudited)
 
 
 
 
(in thousands)
 
Raw materials
$
48
 
$
48
 
Finished goods
 
43
 
 
62
 
Total
$
91
 
$
110
 

6.
Accumulated Other Comprehensive Income (Loss)

Net comprehensive income (loss) for the three and nine months ended October 31, 2010 and November 1, 2009, respectively, is as follows (in thousands):
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
October 31,
2010
 
 
November 1,
2009
 
 
October 31,
2010
 
 
November 1,
2009
 
Net income (loss)
 
$
(129
)
 
$
2,505
 
 
$
(1,388
)
 
$
1,645
 
Net change in unrealized loss on
  available for sale securities
 
 
 
 
 
 
 
 
 
 
 
 
Net comprehensive income (loss)
 
$
(129
)
 
$
2,505
 
 
$
(1,388
)
 
$
1,645
 

The Company had no accumulated other comprehensive income (loss) for the quarters ended October 31, 2010 and November 1, 2009.

7.
Obligations Under Capital Leases

For the three and nine months ended October 31, 2010 and November 1, 2009, the Company had no obligations under capital leases.
 
8.
Warrant Liability

On December 6, 2006, NeoMagic closed the sale and issuance to various investors of (i) 2,500,000 shares of its Common Stock (the “2006 Shares”), and (ii) warrants to purchase 1,250,000 shares of Common Stock at an exercise price of $5.20 per share (the “2006 Warrants”). The Company sold and issued the 2006 Shares and the 2006 Warrants for an aggregate offering price of $11.5 million. After deducting offering costs, net cash proceeds received by the Company were $10.5 million.

The 2006 Warrants provide that each holder of a 2006 Warrant may exercise its 2006 Warrant for shares of Common Stock at an exercise price of $5.20 per share. No 2006 Warrant is exercisable until six months after the issuance date of such 2006 Warrant. The 2006 Warrants provide for adjustments to the exercise price and number of shares for which the 2006 Warrants may be exercised in certain circumstances, including stock splits, stock dividends, certain distributions and reclassifications, and dilutive issuances, subject to a minimum price of $4.58 per share. On October 16, 2009, NeoMagic closed the sale and issuance of additional shares of its Common Stock and warrants to purchase Common Stock (described below), which triggered the anti-dilution provision in the 2006 Warrants. An adjustment was made to increase the number of shares subject to the 2006 Warrants from 1,250,000 to 1,419,214 shares of common stock and to decrease the exercise price from $5.20 to $4.58 per share. As of October 31, 2010, none of the 2006 Warrants had been exercised.

The Company is required to revalue the 2006 Warrants, utilizing the Black-Scholes pricing model, at the end of each reporting period with the change in value reported in the statement of operations as a “gain or loss from the change in fair value on revaluation of warrant liability” in the period in which the change occurred. As of October 31, 2010, the Warrants had a fair market value of $0 compared to $2 thousand at January 31, 2010.
 
 
9

 

9.
Income Taxes

The Company maintained a full valuation allowance on its net deferred tax assets as of the nine months ended October 31, 2010 and November 1, 2009.

The Company believes an ownership change as defined under Section 382 of the Internal Revenue Code of 1986, as amended, may exist. The Company is currently analyzing the ownership change to determine the limitations on the ability to utilize net operating loss and tax credit carryforwards under Sections 382 and 383 of the Internal Revenue Code in future periods due to significant stock transactions in previous years. Such limitations may limit the future realization of the Company’s net operating losses and tax credits. In addition, a portion of the federal research tax credit carryforwards may be subject to forfeiture due to Section 383 limitations. The Company is in the process of determining the impact of Section 383 on the tax credit carryforwards.

In June 2006, the Financial Accounting Standards Board (FASB) issued ASC 740, “Accounting for Uncertainty in Income Taxes” (“ASC 740”). ASC 740 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements in accordance with Statement of Financial Accounting Standards No. 109, “Accounting for Income Taxes” (“FAS 109”). This interpretation prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on derecognition of tax benefits, classification on the balance sheet, interest and penalties, accounting in interim periods, disclosure, and transition. The Company adopted ASC 740 effective January 29, 2007. In accordance with ASC 740, the Company has decided to classify interest and penalties as a component of tax expense.

The Company is subject to audit by the IRS for all years since fiscal 2007, and to audit by the California Franchise Tax Board for all years since fiscal 2006.

10.
Commitments and Contingencies

In January 2009, the Company moved its principal headquarters to a facility in San Jose, California, under a non-cancelable operating lease that expired in January 2010. In January 2010, the Company moved its principal headquarters to a larger facility in San Jose, California under a non-cancelable operating lease that expires in January 2012. The Company’s former subsidiaries had leased offices in Israel and India under operating leases that expired in fiscal year 2009. During fourth quarter of fiscal 2009, the offices in Israel and India were vacated. In accordance with the guidance provided by ASC 810-10 and on guidance of legal counsel, beginning with the third fiscal quarter of fiscal year 2010, the Company no longer consolidates the financial statements of its previously consolidated subsidiaries in Israel and India. The liabilities from the two subsidiaries that were previously included in consolidation were primarily accrued expenses for accounts payable, bonus, vacation, and other expenses. The Company believes that any recognition of a liability would not fairly present the current situation. The amounts previously shown as an accrued liability in consolidation have been reversed and are shown as a gain on debt forgiveness in fiscal 2010. As of October 31, 2010, future minimum lease payments under the Company’s operating leases are as follows:

 
 
(in thousands)
 
Fiscal 2011
 
$
10
 
Fiscal 2012
 
 
42
 
Total minimum lease payments
 
$
52
 

Design tool software licenses

We had no commitments under time-based subscription licenses for design tool software for the quarter ended October 31, 2010.

Other Commitments

On February 4, 2010, NeoMagic and Douglas R. Young, its former President and Chief Executive Officer (the “Executive”), entered into a Separation Agreement and Release of Claims, as well as a Consulting Agreement. Both Agreements became effective on February 11, 2010. The Separation Agreement provides that the Company will pay $50,000 to the Executive within ninety days after the Effective Date and $235,000 in 26 equal payments over the 12 month period following the Effective Date. All unvested options previously granted to the Executive will also accelerate and become vested on the Effective Date. We also recognized the stock option non-cash expense of $152 thousand for Mr. Young’s stock options. As of October 31, 2010, the Company had paid $223 thousand of the cash settlement with the remainder to be paid monthly over 4 months.
 
 
10

 

Under the Consulting Agreement, which has a term of 6 months, Mr. Young will provide four hours of marketing, sales and related consulting services each month without further charge and up to an additional 26 hours of consulting each month, upon the Company's request, for $300 per hour. In consideration for such commitments, the Company agreed to pay Mr. Young a total of $25,000, payable in 6 equal monthly installments, and to grant him Non-Qualified Stock Options entitling him to purchase 5 million shares of the Company's stock, subject to the Company obtaining the necessary stockholder and regulatory approvals. The options were issued on June 30, 2010 and options to purchase 3 million shares, which had been subject to an exercise price of the greater of $.06 a share or the closing price for the Company's stock in the "pink sheets" on the date of grant, were granted at the closing price for the Company’s common stock on June 30, 2010 of $0.07 per share. The price for the other options for 2 million shares were issued on June 30, 2010, and had been subject to an exercise price of the greater of $0.15 a share or the closing price for the Company's stock in the "pink sheets" on the date of grant, were granted at $0.15 per share since the closing price for the Company’s common stock on June 30, 2010 was $0.07 per share. All options vested immediately upon grant and are exercisable for a period of 3 years from the grant date. As of October 31, 2010, the Company has paid the cash settlement of $25 thousand and the Company has recognized a one-time non-cash compensation expense of $350 thousand for the issuance of the fully vested stock options.

We had compensation commitments to former employees and, under Employment Agreements, with four former officers of the Company for $903 thousand. During fiscal 2010, we paid in full all amounts due to former non-officer employees and settled the claims of three former officers for cash of $417 thousand and the issuance of 200,000 restricted unregistered shares of the Company’s common stock. As of October 31, 2010, the Company had paid $82 thousand of the cash settlement with the remainder to be paid monthly over a six month period. The Company also had a compensation commitment of $422 thousand with its current employees. This debt was settled for cash payments of $210 thousand during fiscal 2010.

On May 5, 2010, the Company entered into a Master Development and License Agreement (the “Agreement”) with Synapse Design Automation, Inc., in which Synapse will design and implement (analog & digital) a USB 3.0 transceiver (USB Transceiver IP) that the Company expects to use in a semiconductor chip to be manufactured, as well as successor chips. The Agreement supersedes the memorandum of understanding between the parties as referenced in the Company’s Form 8-K filed on April 9, 2010.

Under the Agreement the parties shall jointly own the USB Transceiver IP and agree to cooperate regarding protecting the USB Transceiver IP. Pursuant to the terms of the Agreement, the Company agrees to pay Synapse up to $1,000,000 for its development work ($200,000 of which was due on the later of (i) the start date for such development work and (ii) the effective date of the Agreement) and Synapse is responsible for providing (at its own expense) all services, personnel, equipment, licenses and other supplies required to perform such services. Payments by the Company in excess of the initial $200,000 are subject to the achievement of milestones by Synapse in the development of the USB Transceiver IP. On May 7, 2010, the Company paid Synapse the initial $200 thousand under the Agreement. We are re-evaluating the Synapse Agreement as part of an overall strategy to develop a suite of USB 3.0 products with greater potential.

11.
Product Warranty

The Company generally sells its products with a limited warranty and a limited indemnification of customers against intellectual property infringement claims. The Company accrues for known warranty and indemnification issues if a loss is probable and can be reasonably estimated, and accrues for estimated incurred but unidentified claims based on historical activity. The accrual and the related expense for known claims was not significant as of and for the three and nine months ended October 31, 2010 and November 1, 2009, due to product testing, the short time between product shipment and the detection and correction of product failures, and a low historical rate of payments on indemnification claims.

12.
Recent Accounting Pronouncements

In January 2010, the Financial Accounting Standards Board (“FASB”) issued an amendment regarding improving disclosures about fair value measurements. This new guidance requires some new disclosures and clarifies some existing disclosure requirements about fair value measurement. The new disclosures and clarifications of existing disclosures are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. Our adoption of the disclosure amendment did not have any impact on the Company’s financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants (“AICPA”) and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

13.
Customer Concentration
 
One customer accounted for 99.9% and 100% of our revenue for the three and nine months ended October 31, 2010.  The same customer account for 100% of the Company’s revenue for each of the three and nine months ended November 1, 2009.  The same customer accounted for $83 thousand and $185 thousand of our net outstanding accounts receivable for the three and nine months ended October 31, 2010 and November 1, 2009, respectively.
 
 
11

 


Item 2.
  Management’s Discussion and Analysis of Financial Condition and Results of Operations

When used in this discussion, the words “will,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such statements reflect management’s current intentions and expectations. However, actual events and results could differ materially based on a variety of factors including, but not limited to: development of new semiconductor chips, customer acceptance of new NeoMagic products, the market acceptance of handheld devices developed and marketed by customers that use our products, our ability to execute product and technology development plans on schedule, and our ability to access advanced manufacturing technologies in sufficient capacity without significant cash pre-payments or investment. Examples of forward-looking statements include statements about our expected resumption in full of orders for our MM3 products from our Singapore customer, our expected revenues, our competitive advantage in our markets, potential market for our products, our expected production timelines, our customer base, and our need for additional financing beyond the next 12 months. These statements are subject to significant risks and uncertainties, including those set forth below under Item 1A of Part II of this Quarterly Report on Form 10-Q and elsewhere in this Quarterly Report on Form 10-Q, and in other reports filed with the SEC, including our Annual Report on Form 10-K for the year ended January 31, 2010, that could cause actual results to differ materially from those projected. These forward-looking statements speak only as of the date hereof. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein, to reflect any changes in our expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based.

Overview

NeoMagic designs and delivers consumer electronic device solutions with semiconductors and software for video, television, imaging, graphics, and audio. We provide low cost, innovative chip technology for tomorrow's entertainment and communication needs. We continue to deliver semiconductor chips (primarily from our MiMagic 3 product line), software and device designs. Our solutions offer low power consumption, small form-factor and high performance processing. As part of our complete system solution, we deliver a suite of middleware and sample applications for imaging, video and audio functionality, and we provide multiple operating system ports with customized drivers for our products. Our product portfolio includes semiconductor solutions known as Applications Processors. Our Applications Processors are sold under the “MiMagic” brand name with a focus on enabling high performance processor within a low power consumption environment. The Company has developed the Horizon Digital Picture Frame kit using our existing MiMagic 6+ application processor. We are also developing new technology and on May 5, 2010, we entered into a Master Development and License Agreement with Synapse Design Automation, Inc., to design and implement (analog and digital) a USB 3.0 super speed transceiver that the Company expects to use in a semiconductor chip to be manufactured.  We are re-evaluating the Synapse Agreement as part of an overall strategy to develop a suite of USB 3.0 products with greater potential.

On August 19, 2010, the Board of Directors appointed Charles Bellavia and Scott Sullinger as directors of the Company. Mr. Bellavia and Mr. Sullinger became members of the Board of Directors effective August 30, 2010. Messrs. Bellavia and Sullinger will serve on our Nominating and Governance committee.

In connection with their appointment to the Board, the Company granted each of Messrs. Bellavia and Sullinger a non-qualified stock option for the purchase of 150,000 shares of the Company’s common stock at an exercise price per share equal to the fair market value of the closing price of the Company’s common stock on August 30, 2010. Assuming continued service on the Company’s Board, such options will vest at the rate of 25% on August 30, 2011 and the remaining amount shall vest at the rate of 1/36th monthly thereafter so that the options shall be exercisable in full in the 48th month. In conjunction with their appointment to our Nominating and Governance committee, Messers. Bellavia and Sullinger have each been granted a non-qualified stock option for the purchase of 80,000 shares of the Company’s common stock at an exercise price per share equal to the fair market value of the closing price of the Company’s common stock on September 2, 2010. Assuming continued service on the Company’s Board, such options will vest at the rate of 1/24th monthly for twenty-four months so that the options shall be exercisable in full in the 24th month.
 
 
12

 

Subsequent to our second fiscal quarter ended August 1, 2010, we received notification from our Singapore customer that beginning in our fiscal fourth quarter 2011, orders for our MM3 were cancelled due to a near-term decreased demand. During our third fiscal quarter ended October 31, 2010, our Singapore customer resumed orders but at a significantly reduced rate than prior quarters. Full shipments are expected to resume in April 2011.

NeoMagic Corporation was incorporated in California in May 1993 and subsequently reincorporated in Delaware in February 1997. Our common stock trading is conducted on the “pink sheets” under the nmgc.pk symbol.

The Company’s fiscal year end is the last Sunday in January. The third fiscal quarters of 2011 and 2010 ended on October 31, 2010 and November 1, 2009, respectively. The Company’s quarters generally have 13 weeks. The third quarter of fiscal 2011 and fiscal 2010 had 13 weeks. The Company’s fiscal years generally have 52 weeks. Fiscal year 2011 has 52 weeks and fiscal year 2010 had 53 weeks.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of such statements requires us to make estimates and assumptions that affect the reported amounts of revenues and expenses during the reporting period and the reported amounts of assets and liabilities as of the date of the financial statements. Our estimates are based on historical experience and other assumptions that we consider to be appropriate in the circumstances. However, actual future results may vary materially from our estimates.

We believe that the following accounting policies are “critical” as defined by the SEC, in that they are both highly important to the portrayal of our financial condition and results, and require difficult management judgments and assumptions about matters that are inherently uncertain:

1.
revenue recognition;
2.
inventory valuation;
3.
deferred taxes and tax accruals; and
4.
fair value of equity instruments.

There have been no significant changes to these policies from the disclosures noted in our Annual Report on Form 10-K for the fiscal year ended January 31, 2010.

Results of Operations

Revenue

Net revenue was $275 thousand for the three months ended October 31, 2010 compared to $348 thousand for the three months ended November 1, 2009, and consisted entirely of net product revenue in both quarters. Net revenue was $807 thousand for the nine months ended October 31, 2010, compared to $1,204 thousand for the nine months ended November 1, 2009, and consisted entirely of net product revenue. Net product revenue decreased in the three and nine months ended October 31, 2010 and November 1, 2009, primarily due to a decrease in shipments of our MiMagic 3 applications processor.

One customer accounted for 99.9% and 100% of our revenue for the three and nine months ended October 31, 2010.  The same customer account for 100% of the Company’s revenue for each of the three and nine months ended November 1, 2009.  The same customer accounted for $83 thousand and $185 thousand of our net outstanding accounts receivable for the three and nine months ended October 31, 2010 and November 1, 2009, respectively.

Product sales to customers located outside the United States (including sales to the foreign operations of customers with headquarters in the United States, and foreign system manufacturers that sell to United States-based OEMs) accounted for 100% of product revenue for each of the three and nine months ended October 31, 2010 and November 1, 2009. In the three and nine months ended October 31, 2010 and November 1, 2009, 99.9% and100%, respectively, of our revenue resulted from the sale of our MiMagic 3 application processor. We expect that export sales will continue to represent the majority of our product revenue in future periods.
 
 
13

 

Our customer base can shift significantly from period to period as some customer programs end and new programs do not always emerge to replace them. In addition, new customers may be added from period to period. All sales transactions were denominated in United States dollars. The following is a summary of the Company’s product revenue by major geographic area:
 
Three Months Ended
 
October 31,
2010
 
November 1,
 2009
Singapore
 
 
99.9%
 
100%
UK
   
.1%
 
        Total
   
100%
 
100%
 
Gross Profit

Gross profit was $157 thousand and $174 thousand for the three months ended October 31, 2010 and November 1, 2009, respectively. Gross profit for the nine months ended October 31, 2010 and November 1, 2009, was $469 thousand and $672 thousand, respectively. The decrease in gross profit for the three and nine months ended October 31, 2010 and November 1, 2009, is primarily due to a reduction in shipments of our MM3 application processor.

Research and Development Expenses

We believe the timely development and introduction of new products are essential to maintaining our competitive position and our ability to capitalize on market opportunities. NeoMagic’s research and development efforts are focused on developing Integrated System-on-Chip semiconductor products. Research and development expenses were $62 thousand and $131 thousand for the three months ended October 31, 2010 and November 1, 2009, respectively. Research and development expenses decreased in the third quarter of fiscal 2011 primarily due to decreased compensation expenses. Research and development expenses for the nine months ended October 31, 2010 and November 1, 2009, was $490 thousand and ($366) thousand, respectively. The increase in fiscal 2011 was primarily due to USB 3.0 transceiver (USB Transceiver IP) that the Company expects to use in a semiconductor chip to be manufactured, as well as successor chips, and increased labor expenses compared to a credit in fiscal 2010 for patent related activity including cancellation of a patent transfer. None of our research and development is customer funded. Our research and development activities are focused on new product development and supporting customer programs based on the MiMagic 3 and MiMagic 6+ products and new chip development.
 
Sales, General and Administrative Expenses

Sales, general and administrative expenses were $225 thousand and $269 thousand for the three months ended October 31, 2010 and November 1, 2009, respectively. Sales, general and administrative expenses increased primarily due to increased non-cash expense for stock options granted and a cash expense for an employment settlement with our former CEO. Sales, general and administrative expenses were $1.4 million and $2.3 million for the nine months ended October 31, 2010 and November 1, 2009, respectively. Sales, general and administrative expenses decreased primarily due to decreased labor costs, legal expenses, and operational expenses.

Stock Compensation

Stock compensation expense was $115 thousand and $84 thousand for the three months ended October 31, 2010 and November 1, 2009, respectively. For the nine months of fiscal 2011 and fiscal 2010, stock compensation expense was $635 thousand and $267 thousand, respectively. Stock compensation expense recorded in cost of revenue, research and development expenses and sales, general and administrative expenses, is the amortization of the fair value of share-based payments made to employees, consultants, and members of our board of directors in the form of stock options and purchases under the employee stock purchase plan as we adopted the provision of ASC 718, “Share-Based Payment”, on the first day of fiscal 2007. The fair value of stock options granted and rights granted to purchase our common stock under the employee stock purchase plan is recognized as expense over the requisite service period.
 
 
14

 

Interest Income and Other

The Company earns interest on its cash, cash equivalents, and short-term investments. For the nine months ended October 31, 2010 and November 1, 2009, interest and other income was $2 thousand and $25 thousand, respectively.

Interest Expense

The Company incurred minimal interest expense in the quarters ended October 31, 2010 and November 1, 2009.

Gain from Change in Fair Value of Warrant Liability

The Company recorded a gain of $2 thousand in its first nine months of fiscal 2011 for the change in fair value on revaluation of its warrant liability associated with its warrants issued on December 6, 2006 (the “2006 Warrants”) compared to a loss in its first nine months of fiscal 2010 of $7 thousand. The 2006 Warrants provide for adjustments to the exercise price per share and number of shares for which the 2006 Warrants may be exercised in certain circumstances, including stock splits, stock dividends, certain distributions, reclassifications and, subject to a minimum price of $4.58 per share, dilutive issuances (i.e., price based anti-dilution adjustments). On October 16, 2009, NeoMagic closed the sale and issuance of additional shares of its Common Stock and warrants to purchase Common Stock, which triggered the anti-dilution provision in the 2006 Warrants. An adjustment was made to increase the number of shares subject to the 2006 Warrants from 1,250,000 to 1,419,214 shares of common stock and to decrease the exercise price from $5.20 to $4.58 per share. As of October 31, none of the 2006 Warrants had been exercised.

Income Taxes

The Company maintained a full valuation allowance on its net deferred tax assets as of October 31, 2010 and November 1, 2009. The valuation allowance was determined using an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable; such assessment is required on a jurisdiction by jurisdiction basis. The Company intends to maintain a full valuation allowance on the U.S. deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance.

The Company believes an ownership change as defined under Section 382 of the Internal Revenue Code may exist. The Company is currently analyzing the ownership change to determine the limitations on the ability to utilize net operating loss and tax credit carryforwards under Sections 382 and 383 of the Internal Revenue Code in future periods due to significant stock transactions in previous years. Such limitations may limit the future realization of the Company’s net operating losses and tax credits. In addition, a portion of the federal research tax credit carryforwards may be subject to forfeiture due to Section 383 limitations. The Company is in the process of determining the impact of Section 383 on the tax credit carryforwards.

Liquidity and Capital Resources

At October 31, 2010, we had $437 thousand in cash and cash equivalents and $83 thousand in accounts receivable as compared to $31 thousand in cash and cash equivalents and $185 thousand in accounts receivable at January 31, 2010.

The Company does not believe its current cash and cash equivalents will satisfy its projected cash requirements through the next twelve months and there exists substantial doubt about the Company’s ability to continue as a going concern. The audit report of our independent registered public accounting firm with respect to our fiscal year ended January 31, 2010, included an explanatory paragraph for a “going concern”. During the quarter ended October 31, 2010, the Company decreased its cash expenditures by reducing employees’ compensation by 21%.  The Company is taking steps to generate cash by seeking funding from strategic partners and further equity financing. While we may secure financing independently, the Company is currently in talks with several groups who specialize in financing Silicon Valley high-tech companies. We anticipate finalization of our strategy in pursuing further financing during our fourth quarter ended January 30, 2011. We cannot assure you that further financing will be available on acceptable terms or at all. The adequacy of the Company’s resources will depend largely on its ability to complete additional financing and its success in re-establishing profitable operations and positive operating cash flows. Subsequent to our second fiscal quarter ended August 1, 2010, we received notification from our Singapore customer that beginning in our fiscal fourth quarter 2011, orders for our MM3 were cancelled due to a near-term decreased demand. During our third fiscal quarter ended October 31, 2010, our Singapore customer resumed orders but at a significantly reduced rate than prior quarters. Full shipments are expected to resume in April 2011.
 
 
15

 
 
Cash and cash equivalents used in operating activities was $1.1 million for the nine months ended October 31, 2010 as compared to $563 thousand for the nine months ended November 1, 2009. The net cash used in operating activities for the nine months ended October 31, 2010 was primarily due to a net loss of $1.4 million, which included a decrease of $102 thousand in accounts receivable, a net decrease of $50 thousand in inventory, and a non-cash expense stock based compensation of $635 thousand, off-set by a decrease in accounts payable of $245 thousand and a decrease in compensation related benefits of $273 thousand and a decrease in commissions payable of $75 thousand. The net cash used in operating activities for the nine months ended November 1, 2009, was primarily due to a reduction in operating income for a non-cash gain on debt forgiveness of $2.5 million, a decrease in compensation and related benefits liability of $298 thousand, a decrease in patent related expense of $270 thousand, and an increase in accounts receivable of $94 thousand, off-set by a non-cash stock-based compensation expense of $267 thousand, an increase in accounts payable of $347 thousand, and an increase in other accruals of $281 thousand.

Net cash provided by financing activities was $1.6 million for the nine months ended October 31, 2010. The net cash provided by financing activities in the nine months ended October 31, 2010, was due to net proceeds of $314 thousand and $185 thousand from the issuance of common stock received for private financings, which closed on February 11, 2010 and March 25, 2010, respectively. Additionally, we received $1.06 million from the exercise of Class A Warrants by two major stockholders on March 25, 2010. Net cash provided by financing activities was $0.7 million for the nine months ended November 1, 2009. The net cash provided by financing activities for the nine months ended November 1, 2009, was due to net proceeds from the issuance of common stock.
 
Off-Balance Sheet Arrangements

As of October 31, 2010, we had no off-balance sheet arrangements as defined in Item 303(a) (4) of Regulation S-K.

Recent Accounting Pronouncements

Please refer to Note 12 of Notes to our condensed consolidated financial statements included in Item 1 of Part I for a discussion of the expected impact of recently issued accounting standards.
 
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
 
Not Applicable.
 
Item 4.
Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures

As of the October 31, 2010, under the supervision of our Chief Executive Officer and our Vice President of Finance and Administration (Principal Accounting Officer), we evaluated the effectiveness of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) and Rule 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”). Based on this evaluation, our Chief Executive Officer and our Vice President of Finance and Administration have concluded that our disclosure controls and procedures were effective as of October 31, 2010 to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and is accumulated and communicated to management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Controls over Financial Reporting

Effective internal controls are necessary for us to provide reliable financial reports. If we do not provide reliable financial reports or prevent fraud, we will be subject to potential liability and may have to incur expenses to defend the Company against governmental proceedings or private litigation and/or to pay fines or damages. Such proceedings would also require significant management time and would distract management from focusing on the business. Failing to provide reliable financial reports would also cause loss of reputation in the investor community and would likely result in a decrease in our stock price.
 
 
16

 

There were no changes in our internal control over financial reporting that occurred during the three and nine months ended October 31, 2010 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
Inherent Limitations on Effectiveness of Controls

The effectiveness of any system of internal control over financial reporting is subject to inherent limitations, including the risk of exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate the risk of misconduct completely. Accordingly, any system of internal control over financial reporting can only provide reasonable, not absolute, assurances. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but we cannot assure that such improvements will be sufficient to provide us with effective internal control over financial reporting.
 
 
17

 
 
Part II. Other Information
 
Item 1A.
Risk Factors
 
The factors discussed below are cautionary statements that identify important risk factors that could cause actual results to differ materially from those anticipated in the forward-looking statements in this Quarterly Report on Form 10-Q.  If any of the following risks actually occurs, our business, financial condition and results of operations would suffer. In this case, the trading price of our common stock could decline and investors might lose all or part of their investment in our common stock.
 
We Need Additional Capital

The Company does not believe its current cash and cash equivalents will satisfy its projected cash requirements through the next twelve months and there exists substantial doubt about the Company’s ability to continue as a going concern. The audit report of our independent registered public accounting firm with respect to our fiscal year ended January 31, 2010, included an explanatory paragraph for a “going concern”. If the Company experiences a material shortfall versus its plan for fiscal 2011, it expects to take all appropriate actions to ensure the continuing operation of its business and to mitigate any negative impact on its cash position. Subsequent to our second fiscal quarter ended August 1, 2010, we received notification from our Singapore customer that beginning in our fiscal fourth quarter 2011, orders for our MM3 were cancelled due to a near-term decreased demand. During our third fiscal quarter ended October 31, 2010, our Singapore customer resumed orders but at a significantly reduced rate than prior quarters. Full shipments are expected to resume in April 2011.

At October 31, 2010, we had $437 thousand in cash and cash equivalents and $83 thousand in accounts receivable.  We believe that this level of cash, cash equivalents, and accounts receivable is not sufficient to maintain continuing operations at current levels. We are not generating sufficient cash from the sale of our products to support our operations and have been incurring significant losses. We have been funding our operations primarily with the cash proceeds of the sale of our MM3 application processor, from the net proceeds of $734 thousand we received in our third fiscal quarter ended November 1, 2009, from a private equity financing, and from the proceeds of subsequent financings. The Company has used the proceeds from the sale of the Securities for general corporate purposes, including general and administrative expenses and payment of outstanding liabilities, and not to redeem or repurchase the Company's Securities. In the quarter ended May 2, 2010, we completed a private financing on February 11, 2010 and we completed an additional private financing on March 25, 2010, for net proceeds of $314 thousand and $185 thousand, respectively. On March 25, 2010, two of our major investors exercised their Class A Warrants, which they obtained on October 16, 2009, for net proceeds of $1.06 million. The proceeds for the first quarter fiscal 2011 private financings and the exercise of Class A Warrants is being used for general corporate purposes, including new product development, general and administrative expenses and payment of outstanding liabilities, and not to redeem or repurchase the Company's Securities. We incurred additional operating losses through the end of our quarter ended October 31, 2010. Unless we are able to increase sales and raise additional capital, we will not have sufficient cash to support our operations.

There is no assurance that we will be generating a sufficient cash flow from operations or obtaining sufficient funding from any source on acceptable terms, if at all. If we are unable to generate sufficient cash flows from our operations, we may not be able to continue operations as proposed, requiring us to modify our business plan, curtail various aspects of our operations or cease operations. In such event, investors may lose a portion or all of their investment. The report of our independent registered public accounting firm, in respect of our 2010 fiscal year, included an explanatory going concern paragraph regarding substantial doubt as to our ability to continue as a going concern, which indicates an absence of obvious or reasonably assured sources of future funding that will be required by us to maintain ongoing operations.

We Have a Limited Customer Base

In the quarters ended October 31, 2010 and November 1, 2009, 99.9% and 100%, respectively, of our product revenue came from one customer. We expect that a small number of customers will continue to account for a substantial portion of our product revenue for the foreseeable future. As our newly announced products become available and achieve customer acceptance, we expect our customer base to increase. Furthermore, the majority of our sales were made, and are expected to continue to be made, on the basis of purchase orders rather than pursuant to long-term purchase agreements. As a result, our business, financial condition and results of operations could be materially adversely affected by the decision of a single customer to cease using our products, or by a decline in the number of devices sold by a single customer. Subsequent to our second fiscal quarter ended August 1, 2010, we received notification from our Singapore customer that beginning in our fiscal fourth quarter 2011, orders for our MM3 were cancelled due to a near-term decreased demand. During our third fiscal quarter ended October 31, 2010, our Singapore customer resumed orders but at a significantly reduced rate than prior quarters. Full shipments are expected to resume in April 2011.
 
 
18

 

We May Lose Our Customer Base

Our products are designed to afford device manufacturer significant advantages with respect to product performance, power consumption and product size. To the extent that other future developments in components or subassemblies incorporate one or more of the advantages offered by our products, the market demand for our products may be negatively impacted.

Our Common Stock is Traded on the “Pink Sheets”

Trading in our common stock is now conducted on the “pink sheets” under the nmgc.pk symbol. Our common stock is experiencing a low trading volume. As such, the price may be easily affected by a single trade or an individual. In addition, many brokerages may choose not to trade in, or implement substantial restrictions on, trading in stock reported on the pink sheets. Price fluctuations during a delay can result in the failure of a limit order to execute or cause execution of a market order at a price significantly different from the price prevailing when an order was entered. Consequently, one may be unable to trade in our common stock at optimum prices. While we are taking steps to improve the liquidity of our stock and increase our shareholder base, and in the future we anticipate listing on a national market exchange, there can be no assurance as to when or if, such results will be obtained.

A Lack of Effective Internal Control over Financial Reporting Could Result in an Inability to Accurately Report Our Financial Results

Effective internal controls are necessary for us to provide reliable financial reports. If we do not provide reliable financial reports or prevent fraud, we will be subject to potential liability and may have to incur expenses to defend the Company against governmental proceedings or private litigation and/or to pay fines or damages. Such proceedings would also require significant management time and would distract management from focusing on the business. Failing to provide reliable financial reports would also cause loss of reputation in the investor community and would likely result in a decrease in our stock price.

Our Revenues Are Difficult to Predict

For a variety of reasons, our revenues are difficult to predict and may vary significantly from quarter to quarter. Our ability to achieve design wins depends on a number of factors, many of which are outside of our control, including changes in the customer’s strategic and financial plans, competitive factors and overall market conditions. As our experience demonstrates, design wins themselves do not always lead to production orders because the customer may cancel or delay products for a variety of reasons. Such reasons may include the performance of a particular product that may depend on components not supplied by NeoMagic, market conditions, reorganizations or other internal developments at the customer and changes in customer personnel or strategy. Even when a customer has begun volume production of a product containing our chips, volumes are difficult to forecast because there may be no history to provide a guide, and because market conditions and other factors may cause changes in the customer’s plans. Because of the market uncertainties they face, many customers place purchase orders on a short lead-time basis, rather than providing reliable long-term purchase orders or purchase forecasts. Our customer base can shift significantly from period to period as existing customer programs end and new programs do not always replace ending programs. All of these factors make it difficult to predict our revenues from period to period.

The difficulty in forecasting revenues increases the difficulty in anticipating our inventory requirements. This difficulty increases the likelihood that we may overproduce particular parts, resulting in inventory write-downs, or under-produce particular parts, affecting our ability to meet customer requirements. The difficulty in forecasting revenues also restricts our ability to provide forward-looking revenue and earnings guidance to the financial markets and increases the chance that our revenue performance does not match investor expectations.
 
 
19

 

We May Encounter Inventory Excess or Shortage

To have product inventory to meet potential customer purchase orders, we place purchase orders for semiconductor wafers from our manufacturer in advance of having firm purchase orders from our customers. If we do not have sufficient demand for our products and cannot cancel our current and future commitments without material impact, we may experience excess inventory, which will result in an inventory write-down affecting gross margin and results of operations. If we cancel a purchase order, we must pay cancellation penalties based on the status of work in process or the proximity of the cancellation to the delivery date. We must place purchase orders for wafers before we receive purchase orders from our own customers. This limits our ability to react to fluctuations in demand for our products, which can be unexpected and dramatic, and from time to time will cause us to have an excess or shortage of wafers for a particular product. As a result of the long lead-time for manufacturing wafers and the increase in “just-in-time” ordering by customers, semiconductor companies from time-to-time take charges for excess inventory. We have a manufacturing relationship with our vendor who procures wafers for us and who assembles and tests our product. During the three and nine months ended October 31, 2010 we recovered $31 thousand in inventory and scrapped the material as it was no longer required. For the three and nine months ended November 1, 2009, no such reserves were taken. Conversely, failure to order sufficient wafers would cause us to miss revenue opportunities and, if significant, could impact sales by our customers, which could adversely affect our customer relationships and thereby materially adversely affect our business, financial condition and results of operations.

We Face Intense Competition in Our Markets

The market for Applications Processors is intensely competitive and is characterized by rapid technological change, evolving industry standards and declining average selling prices. We believe that the principal factors of competition in this market are audio/video performance, price, features, power consumption, product size and customer support, as well as, company stability. Our ability to compete successfully in the Applications Processor market depends on a number of factors, including success in designing and subcontracting the manufacture of new products that implement new technologies, product quality and reliability, price, ramp of production of our products, customer demand, and end-user acceptance of our customers’ products, market acceptance of competitors’ products and general economic conditions. Our ability to compete will also depend on our ability to identify and ensure compliance with evolving industry standards and market trends. Our small size and perceived instability are negative factors in competing for business.

We compete with both domestic and foreign companies, some of which have substantially greater financial and other resources than us with which to pursue engineering, manufacturing, marketing and distribution of their products. We may also face increased competition from new entrants into the market, including companies currently in the development stage. While we believe we have significant expertise in SOC technology, our current application processor technology was developed prior to 2008, and if we cannot timely introduce new products for our markets, support these products in customer programs, or manufacture these products, such inabilities could have a material adverse effect on our business, financial condition and operating results.

Some of our current and potential competitors operate their own manufacturing facilities. Since we do not operate our own manufacturing facility and may from time-to-time make binding commitments to purchase products, we may not be able to reduce our costs and cycle time or adjust our production to meet changing demand as rapidly as companies that operate their own facilities, which could have a material adverse effect on our results of operations. In addition, if production levels increase the value of binding purchase orders may increase significantly.

We Depend on Qualified Personnel

Our future success depends in part on the continued service of our personnel, and our ability to identify, contract or hire and retain additional personnel to serve potential customers in our targeted markets. There is strong competition for qualified personnel in the semiconductor industry, and we cannot assure you that we will be able to continue to attract and retain qualified personnel necessary for the development of our business.

Our Chief Executive Officer, Syed Zaidi, is an employee “at will”. We have an employment contract with Mr. Zaidi. Until his departure, we had an employment contract with our former President and Chief Executive Officer. The employment contract allows us to terminate employment at any time but requires us to make severance payments depending upon the circumstances surrounding termination of employment. Our Principal Accounting Officer, Charlotte Willson, is an employee “at will”. We do not have an employment contract with Ms. Willson. We do not maintain key person insurance on any of our personnel. If we are not able to retain key personnel, if our headcount is not appropriate for our future direction, or if we fail to recruit key personnel critical to our future direction in a timely manner, this may have a material adverse effect on our business, financial condition and results of operations.
 
 
20

 

Our Products May be Incompatible with Evolving Industry Standards and Market Trends

Our ability to compete in the future will also depend on our ability to identify and ensure compliance with evolving industry standards and market trends. Unanticipated changes in market trends and industry standards could render our products incompatible with products developed by major hardware manufacturers and software developers. As a result, we could be required to invest significant time and resources to redesign our products or obtain license rights to technologies owned by third parties to comply with relevant industry standards and market trends. We cannot assure you that we will be able to redesign our products or obtain the necessary third-party licenses within the appropriate window of market demand. If our products are not in compliance with prevailing market trends and industry standards for a significant period of time, we could miss crucial OEM and ODM design cycles, which could result in a material adverse effect on our business, financial condition and results of operations.

We Depend on Third-Party Manufacturers to Produce Our Products

We have a relationship with one contractor to perform manufacturing, assembly, packaging and testing of our products. We work with the contractor for advanced packaging capabilities. We do not have a long-term agreement with the contractor. As a result of our reliance on one contractor to procure wafers, manufacture, assemble, test and provide advanced packaging for our products, we cannot directly control product delivery schedules, which could lead to product shortages or quality assurance problems that could increase the costs of manufacturing or assembling our products. Due to the amount of time normally required to qualify assembly and test contractors, shipments could be delayed significantly if we are required to find alternative contractors.

Our products require wafers manufactured with state-of-the-art fabrication equipment and techniques. Due to the amount of time normally required to qualify the wafer subcontractors, shipments could be delayed significantly if we are required to find an alternative subcontractor foundry, to produce semiconductor wafers for our current products. We do not have a long-term agreement with this foundry. We depend on our wafer supplier to allocate to us a portion of their manufacturing capacity sufficient to meet our needs, to produce products of acceptable cost and quality at acceptable manufacturing yields, and to deliver those products to us on a timely basis. Since, in our experience, the lead time needed to establish a relationship with a new wafer fabrication partner is at least 12 months, and the estimated time for a foundry to switch to a new product line ranges from four to nine months, we may have no readily available alternative source of supply for specific products. In addition to time constraints, switching foundries would require a diversion of engineering manpower and financial resources to redesign our products so that the new foundry could manufacture them. We cannot assure you that we can redesign our products to be manufactured by a new foundry in a timely manner, nor can we assure you that we will not infringe on the intellectual property of our current wafer manufacturer if we were to redesign our products for a new foundry. In addition, due to the reduction of our engineering staff, it is unlikely that we could develop an alternative design. A manufacturing disruption experienced by our manufacturing partner would have a material adverse effect on our business, financial condition and results of operations.

We have many other risks due to our dependence on a third-party manufacturer, including: reduced control over delivery schedules, quality, manufacturing yields and cost, the potential lack of adequate capacity during periods of excess demand, limited warranties on wafers supplied to us, and potential misappropriation of our intellectual property. We are dependent on our manufacturing partner to produce wafers with acceptable quality and manufacturing yields, and to assemble the product, which includes their ability to allocate a portion of their manufacturing capacity sufficient to meet our needs. Although our products are designed using the process design rules of the particular manufacturer, we cannot assure you that our manufacturing partner will be able to achieve or maintain acceptable yields or deliver sufficient quantities of wafers on a timely basis or at an acceptable cost. We have insurance to cover our product in the event of catastrophic natural disasters, however, we cannot assure you that the coverage duration and the coverage amount will be sufficient to bridge a shortfall in revenue. Additionally, we cannot assure you that our manufacturing partner will continue to devote adequate resources to produce our products or continue to advance the process design technologies on which the manufacturing of our products are based.
 
Our Manufacturing Yields May Fluctuate

Fabricating semiconductors is an extremely complex process, which typically includes hundreds of process steps. Minute levels of contaminants in the manufacturing environment, defects in masks used to print circuits on a wafer, variation in equipment used and numerous other factors can cause a substantial percentage of wafers to be rejected or a significant number of die on each wafer to be nonfunctional. Many of these problems are difficult to diagnose and time consuming or expensive to remedy. As a result, semiconductor companies often experience problems in achieving acceptable wafer manufacturing yields, which are represented by the number of good die as a proportion of the total number of die on any particular wafer. We typically purchase wafers, not die, and pay an agreed upon price for wafers meeting certain acceptance criteria. Accordingly, we bear the risk of the yield of good die from wafers purchased meeting the acceptance criteria.
 
 
21

 

Semiconductor manufacturing yields are a function of both product design, which is developed largely by us, and process technology, which is typically proprietary to the manufacturer. Historically, we have experienced lower yields on new products. Since low yields may result from either design or process technology failures, yield problems may not be effectively determined or resolved until an actual product exists that can be analyzed and tested to identify process sensitivities relating to the design rules that are used. As a result, yield problems may not be identified until well into the production process, and resolution of yield problems would require cooperation and communication between the manufacturer and us. This risk is compounded by the offshore location of our manufacturer, increasing the effort and time required to identify, communicate and resolve manufacturing yield problems. As our relationships with new manufacturing partners develop, yields could be adversely affected due to difficulties associated with adapting our technology and product design to the proprietary process technology and design rules of each manufacturer. Any significant decrease in manufacturing yields could result in an increase in our per unit product cost and could force us to allocate our available product supply among our customers, potentially adversely impacting customer relationships as well as revenues and gross margins. We cannot assure you that our manufacturers will achieve or maintain acceptable manufacturing yields in the future.

Uncertainty and Litigation Risk Associated with Patents

As a general matter, the semiconductor industry has experienced substantial litigation regarding patent and other intellectual property rights. Any patent litigation, whether or not determined in our favor or settled by us, would at a minimum be costly and could divert the efforts and attention of our management and technical personnel from productive tasks, which could have a material adverse effect on our business, financial condition and results of operations. We cannot assure you that future infringement claims by third parties or claims for indemnification by customers or end users of our products resulting from infringement claims will not be asserted in the future or that such assertions, if proven to be true, will not materially adversely affect our business, financial condition and results of operations. If any adverse ruling in any such matter occurs, we could be required to pay substantial damages, which could include treble damages, to cease the manufacturing, use and sale of infringing products, to discontinue the use of certain processes, or to obtain a license under the intellectual property rights of the third party claiming infringement. We cannot assure you, however, that a license would be available on reasonable terms or at all. Any limitations in our ability to market our products, or delays and costs associated with redesigning our products or payments of license fees to third parties, or any failure by us to develop or license a substitute technology on commercially reasonable terms could have a material adverse effect on our business, financial condition and results of operations.
 
We Depend on Foreign Sales and Suppliers

Export sales have been a critical part of our business. Sales to customers located outside the United States (including sales to the foreign operations of customers with headquarters in the United States and foreign manufacturers that sell to United States-based OEMs) accounted for 100% of our product revenue for the three and nine months ended October 31, 2010 and November 1, 2009. We expect that product revenue derived from foreign sales will continue to represent a significant portion of our total product revenue. To date, our foreign sales have been denominated in United States dollars. Increases in the value of the U.S. dollar relative to the local currency of our customers could make our products relatively more expensive than competitors’ products sold in the customer’s local currency.

Foreign manufacturers have produced, and are expected to continue to produce for the foreseeable future, all of our wafers. In addition, many of the assembly and test services we use are procured from foreign sources. Wafers are priced in U.S. dollars under our purchase orders with our manufacturing suppliers.

Foreign sales and manufacturing operations are subject to a variety of risks, including fluctuations in currency exchange rates, tariffs, import restrictions and other trade barriers, unexpected changes in regulatory requirements, longer accounts receivable payment cycles, potentially adverse tax consequences and export license requirements. In addition, we are subject to the risks inherent in conducting business internationally including foreign government regulation, political and economic instability, and unexpected changes in diplomatic and trade relationships. Moreover, the laws of certain foreign countries in which our products may be developed, manufactured or sold, may not protect our intellectual property rights to the same extent as do the laws of the United States, thus increasing the possibility of piracy of our products and intellectual property. We cannot assure you that one or more of these risks will not have a material adverse effect on our business, financial condition and results of operations.

Our Financial Results Could Be Affected by Changes in Accounting Principles

Generally accepted accounting principles in the United States are subject to issuance and interpretation by the Financial Accounting Standards Board, or FASB, the American Institute of Certified Public Accountants, the SEC, and various bodies formed to promulgate and interpret appropriate accounting principles. A change in these principles or interpretations could have a significant effect on our reported financial results, and could affect the reporting of transactions completed before the announcement of a change.
 
 
22

 

Our Stock Price May Be Volatile

The market price of our Common Stock, like that of other semiconductor companies, has been and is likely to continue to be, highly volatile. For example, during the third quarter ended October 31, 2010, the highest closing sales price per share was $0.08 and the lowest was less than $0.04. During the quarter ended November 1, 2009, the highest closing sales price was $0.19 and the lowest was less than $0.03 per share. The market has from time to time experienced significant price and volume fluctuations that may be unrelated to the operating performance of particular companies. The market price of our Common Stock could be subject to significant fluctuations in response to various factors, including sales of our common stock, quarter-to-quarter variations in our anticipated or actual operating results, announcements of new products, technological innovations or setbacks by us or our competitors, general conditions in the semiconductor industry, unanticipated shifts in the markets for mobile phones and other handheld devices or changes in industry standards, losses of key customers, litigation commencement or developments, the impact of our financing activities, including dilution to stockholders, changes in or the failure by us to meet estimates of our performance by securities analysts, market conditions for high technology stocks in general, and other events or factors. In future quarters, our operating results may be below the expectations of public market analysts or investors.
 
Item 5.
Other Information
 
None.
 
 
23

 
 
Item 6.
Exhibits

The following exhibits are filed with this Quarterly Report on Form 10-Q:

Number
 
Description
3.1(1)
 
Amended and Restated Certificate of Incorporation.
3.1.2
 
Certificate of Amendment to Restated Certificate of Incorporation
3.2(2)
 
Bylaws, as amended through April 6, 2007.
4.2(3)
 
Amendment to Rights Agreement, dated as of August 20, 2004, between the Company and EquiServe Trust Company, N.A.
4.3(3)
 
Amendment No. 3 to Rights Agreement, dated as of April 6, 2007, between the Company and EquiServe Trust Company, N.A.
4.7(3)
 
Certificate of Designation of Rights, Preferences and Privileges of Series A Participating Preferred Stock.
4.17(3)
 
Amendment No. 5 To Preferred Stock Rights Agreement
4.9(4)
 
Registration Rights Agreement dated December 13, 2005 by and between the Company and named Private Investors.
4.10(4)
 
Warrant to Registration Rights Agreement dated December 13, 2005.
4.11(5)
 
Form of Warrant originally issued December 6, 2006.
4.12(6)
 
Form of Amendment to Warrant, dated July 27, 2007.
4.13(7)
 
Class A Warrant to named Private Investors, dated October 12, 2009
4.14(7)
 
Class B Warrant to named Private Investors, dated October 12, 2009
4.15(7)
 
Class A (Employee) Warrant to named Private Investors, dated October 12,2009/
4.16(7)
 
Class B (Employee) Warrant to named Private Investors, dated October 12, 2009.
10.7(8)
 
2003 Stock Option Plan, as amended and restated April 15, 2010.
10.32(9)
 
Separation Agreement and Release of Claims with Douglas R. Young, dated February 4, 2010.
10.33(10)
 
Consulting Agreement, dated February 4, 2010, with Douglas R. Young
10.34(11)
 
Securities Purchase Agreement dated February 11, 2010, by and between the Company and Named Private Investors.
10.35(12)
 
Securities Purchase Agreement dated March 25, 2010, by and between the Company and Named Private Investors.
10.36(13)
 
Master Development and License Agreement dated May 5, 2010 by and between the Company and Synapse Design Automation, Inc.
16.1(14)
 
Letter dated October 5, 2010 from Stonefield Josephson, Inc. to the US Securities and Exchange Commission
31.1
 
Certification pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
 
Certification pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1
 
Certification pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2
 
Certification pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
(1)
 
Incorporated by reference to an exhibit to the Company’s Form 10-Q for the quarter ended October 30, 2005.
(2)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed April 12, 2007.
(3)
 
Incorporated by reference to the Company’s Form 8-K filed October 16, 2009.
(4)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed December 16, 2005.
(5)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed December 1, 2006.
(6)
 
Incorporated by reference to an exhibit to the Company’s Schedule TO-I filed June 28, 2007.
(7)
 
Securities Purchase Agreement dated October 12, 2009 by and between the Company and named Private Investors Private Investors.
(8)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed April 19, 2010.
(9)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed February 10, 2010.
(10)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed February 10, 2010.
(11)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed February 16, 2010.
(12)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed March 29, 2010.
(13)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed May 11, 2010
(14)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed October 6, 2010
 
 
24

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
NEOMAGIC CORPORATION
(Registrant)
 
 
 
 
 
December 9, 2010
By:
/s/ Syed Zaidi
 
 
 
SYED ZAIDI
President and Chief Executive Officer
(Principal Executive Officer)
 
 
December 9, 2010
By:
/s/ Charlotte A. Willson
 
 
 
CHARLOTTE A. WILLSON
Vice President, Finance and Administration
(Principal Financial Officer)
 
 
 
25

 
 
EXHIBIT INDEX
 
Number
 
Description
3.1(1)
 
Amended and Restated Certificate of Incorporation.
3.1.2
 
Certificate of Amendment to Restated Certificate of Incorporation
3.2(2)
 
Bylaws, as amended through April 6, 2007.
4.2(3)
 
Amendment to Rights Agreement, dated as of August 20, 2004, between the Company and EquiServe Trust Company, N.A.
4.3(3)
 
Amendment No. 3 to Rights Agreement, dated as of April 6, 2007, between the Company and EquiServe Trust Company, N.A.
4.7(3)
 
Certificate of Designation of Rights, Preferences and Privileges of Series A Participating Preferred Stock.
4.17(3)
 
Amendment No. 5 To Preferred Stock Rights Agreement
4.9(4)
 
Registration Rights Agreement dated December 13, 2005 by and between the Company and named Private Investors.
4.10(4)
 
Warrant to Registration Rights Agreement dated December 13, 2005.
4.11(5)
 
Form of Warrant originally issued December 6, 2006.
4.12(6)
 
Form of Amendment to Warrant, dated July 27, 2007.
4.13(7)
 
Class A Warrant to named Private Investors, dated October 12, 2009
4.14(7)
 
Class B Warrant to named Private Investors, dated October 12, 2009
4.15(7)
 
Class A (Employee) Warrant to named Private Investors, dated October 12,2009/
4.16(7)
 
Class B (Employee) Warrant to named Private Investors, dated October 12, 2009.
10.7(8)
 
2003 Stock Option Plan, as amended and restated April 15, 2010.
10.32(9)
 
Separation Agreement and Release of Claims with Douglas R. Young, dated February 4, 2010.
10.33(10)
 
Consulting Agreement, dated February 4, 2010, with Douglas R. Young
10.34(11)
 
Securities Purchase Agreement dated February 11, 2010, by and between the Company and Named Private Investors.
10.35(12)
 
Securities Purchase Agreement dated March 25, 2010, by and between the Company and Named Private Investors.
10.36(13)
 
Master Development and License Agreement dated May 5, 2010 by and between the Company and Synapse Design Automation, Inc.
16.1(14)
 
Letter dated October 5, 2010 from Stonefield Josephson, Inc. to the US Securities and Exchange Commission
31.1
 
Certification pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
 
Certification pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1
 
Certification pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2
 
Certification pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
(1)
 
Incorporated by reference to an exhibit to the Company’s Form 10-Q for the quarter ended October 30, 2005.
(2)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed April 12, 2007.
(3)
 
Incorporated by reference to the Company’s Form 8-K filed October 16, 2009.
(4)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed December 16, 2005.
(5)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed December 1, 2006.
(6)
 
Incorporated by reference to an exhibit to the Company’s Schedule TO-I filed June 28, 2007.
(7)
 
Securities Purchase Agreement dated October 12, 2009 by and between the Company and named Private Investors Private Investors.
(8)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed April 19, 2010.
(9)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed February 10, 2010.
(10)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed February 10, 2010.
(11)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed February 16, 2010.
(12)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed March 29, 2010.
(13)
Incorporated by reference to an exhibit to the Company’s Form 8-K filed May 11, 2010
(14)
 
Incorporated by reference to an exhibit to the Company’s Form 8-K filed October 6, 2010
 
 
26